Table of Contents
International Journal of Molecular Imaging
Volume 2012, Article ID 250834, 8 pages
http://dx.doi.org/10.1155/2012/250834
Research Article

Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group

1Department of Pediatrics, UCSF School of Medicine, 505 Parnassus Avenue, M696, San Francisco, CA 94143-0106, USA
2Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, San Francisco, CA 94143-0912, USA
3Department of Pediatrics, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA
4Epidemiology and Biostatistics, UCSF School of Medicine, San Francisco, CA 94107, USA
5Department of Pathology, Perelman School of Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA
6Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA
7Department of Biostatistics, University of Florida, Gainesville, FL 32611, USA
8Children's Oncology Group Statistics and Data Center, Arcadia, CA 91006-3776, USA
9Department of Pediatrics, Children's Hospital Boston and Dana-Farber Harvard Cancer Center, Boston, MA 02215-5450, USA
10Department of Pediatrics, Duke University School of Medicine, Durham, NC 27705, USA
11Department of Hematology/Oncology, Princess Margaret Hospital for Children, Perth, WA 6008, Australia

Received 3 August 2012; Accepted 23 August 2012

Academic Editor: Jun Hatazawa

Copyright © 2012 Steven G. DuBois et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Gitta Bleeker, Berthe L. van Eck-Smit, Koos H. Zwinderman, Rogier Versteeg, Max M. van Noesel, Boen L. Kam, Gertjan J. Kaspers, Annelies van Schie, Susan G. Kreissman, Gregory Yanik, Barbara Hero, Matthias Schmidt, Geneviève Laureys, Bieke Lambert, Ingrid Øra, Johannes H. Schulte, Huib N. Caron, and Godelieve A. Tytgat, “MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis,” European Journal of Nuclear Medicine and Molecular Imaging, 2014. View at Publisher · View at Google Scholar
  • Keri A. Streby, Nilay Shah, Mark A. Ranalli, Anne Kunkler, and Timothy P. Cripe, “ Nothing but NET: A review of norepinephrine transporter expression and efficacy of 131 I-mIBG therapy ,” Pediatric Blood & Cancer, 2014. View at Publisher · View at Google Scholar
  • Garrett M Brodeur, Radhika Iyer, Jamie L Croucher, Tiangang Zhuang, Mayumi Higashi, and Venkatadri Kolla, “Therapeutic targets for neuroblastomas,” Expert Opinion on Therapeutic Targets, pp. 1–16, 2014. View at Publisher · View at Google Scholar
  • William Temple, Lori Mendelsohn, Grace E. Kim, Erin Nekritz, W. Clay Gustafson, Lawrence Lin, Kathy Giacomini, Arlene Naranjo, Collin Van Ryn, Gregory A. Yanik, Susan G. Kreissman, Michael Hogarty, Katherine K. Matthay, and Steven G. DuBois, “Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children’s Oncology Group,” European Journal of Nuclear Medicine and Molecular Imaging, 2015. View at Publisher · View at Google Scholar
  • Steven G. DuBois, Susan Groshen, Julie R. Park, Daphne A. Haas-Kogan, Xiaodong Yang, Ethan Geier, Eugene Chen, Kathy Giacomini, Brian Weiss, Susan L. Cohn, M. Meaghan Granger, Gregory A. Yanik, Randall Hawkins, Jesse Courtier, Hollie Jackson, Fariba Goodarzian, Hiroyuki Shimada, Scarlett Czarnecki, Denice Tsao-Wei, Judith G. Villablanca, Araz Marachelian, and Katherine K. Matthay, “Phase I Study of Vorinostat as a Radiation Sensitizer with I-131-Metaiodobenzylguanidine (I-131-MIBG) for Patients with Relapsed or Refractory Neurobl,” Clinical Cancer Research, vol. 21, no. 12, pp. 2715–2721, 2015. View at Publisher · View at Google Scholar
  • Marguerite T. Parisi, Hedieh Eslamy, Julie R. Park, Barry L. Shulkin, and Gregory A. Yanik, “131I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications,” Seminars in Nuclear Medicine, vol. 46, no. 3, pp. 184–202, 2016. View at Publisher · View at Google Scholar
  • Yen-Lin Liu, Yung-Ming Jeng, Hsinyu Lee, James S Miser, Kai-Hsin Lin, Yung-Feng Liao, Wen-Ming Hsu, Kai-Yuan Tzen, Meng-Yao Lu, Hsiu-Hao Chang, Ching-Chu Lu, Dong-Tsamn Lin, Shiann-Tarng Jou, Yung-Li Yang, Ya-Ling Lee, and Shiu-Feng Huang, “Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.,” Oncotarget, vol. 7, no. 14, pp. 18774–86, 2016. View at Publisher · View at Google Scholar
  • Rochelle Bagatell, and Susan L. Cohn, “Genetic discoveries and treatment advances in neuroblastoma,” Current Opinion in Pediatrics, vol. 28, no. 1, pp. 19–25, 2016. View at Publisher · View at Google Scholar
  • Katherine K. Matthay, John M. Maris, Gudrun Schleiermacher, Akira Nakagawara, Crystal L. Mackall, Lisa Diller, and William A. Weiss, “Neuroblastoma,” Nature Reviews Disease Primers, vol. 2, pp. 16078, 2016. View at Publisher · View at Google Scholar
  • Neeta Pandit-Taskar, and Shakeel Modak, “Norepinephrine transporter as a target for imaging and therapy,” Journal of Nuclear Medicine, vol. 58, pp. 39–53, 2017. View at Publisher · View at Google Scholar
  • Steven G. DuBois, Rajen Mody, Arlene Naranjo, Collin Van Ryn, Douglas Russ, Derek Oldridge, Susan Kreissman, David L. Baker, Marguerite Parisi, Barry L. Shulkin, Harrison Bai, Sharon J. Diskin, Vandana Batra, John M. Maris, Julie R. Park, Katherine K. Matthay, and Gregory Yanik, “MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group,” Pediatric Blood & Cancer, pp. e26545, 2017. View at Publisher · View at Google Scholar
  • Yanlin Zhao, Xiao Zhong, Xiaohong Ou, Huawei Cai, Xiaoai Wu, and Rui Huang, “Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells,” Frontiers of Medicine, 2017. View at Publisher · View at Google Scholar
  • Vanessa P. Tolbert, and Katherine K. Matthay, “Neuroblastoma: clinical and biological approach to risk stratification and treatment,” Cell and Tissue Research, 2018. View at Publisher · View at Google Scholar
  • John Inge Johnsen, Cecilia Dyberg, Susanne Fransson, and Malin Wickström, “Molecular mechanisms and therapeutic targets in neuroblastoma,” Pharmacological Research, 2018. View at Publisher · View at Google Scholar
  • Akira Nakagawara, Yuanyuan Li, Hideki Izumi, Katsumi Muramori, Hiroko Inada, and Masanori Nishi, “Neuroblastoma,” Japanese Journal of Clinical Oncology, vol. 48, no. 3, pp. 214–241, 2018. View at Publisher · View at Google Scholar